June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

May 11, 2015May 11, 2015

Cryoport Supports NeoStem’s Intus Study For Metastatic Melanoma Treatment

Melanoma, News

New York based biopharmaceutical company, NeoStem, is developing an autologous immunotherapy using patients’ own tumor cells to maximize individuals’ immune system’s ability to identify and eliminate cancer-initiating cells that NeoStem ... Read more

May 8, 2015May 8, 2015

Researchers Discover a Promising New Drug Target for Melanoma Treatment

News

A team of researchers from The University of North Carolina at Chapel Hill have recently reported the discovery of a new drug target for melanoma treatment. The study was published in ... Read more

May 6, 2015May 8, 2015

May is National Melanoma Skin Cancer Prevention Month

Melanoma, News

The month of May has been established by the American Academy of Dermatology as National Melanoma Skin Cancer Prevention Month with the goal of raising awareness of melanoma skin cancer and ... Read more

May 4, 2015May 4, 2015

Amgen Presents Details Of Biologics License Application For Metastatic Melanoma Drug Talimogene Laherparepvec To Joint FDA Advisory Committee

Melanoma, News

A Joint Meeting of the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) and Oncologic Drugs Advisory Committee (ODAC) on Wednesday, April 29, 2015 ... Read more

May 1, 2015May 1, 2015

Indoor Tanning: More Than A Third Of New Jersey Teens Who Engage In Behavior Do So Frequently

News, Skin Cancer

Over a third of New Jersey teenagers practice indoor tanning and, according to a recent study, they do it frequently. Furthermore, those who tan are more likely to be smokers and ... Read more

April 30, 2015April 30, 2015

BioNTech Collaborative Study Reveals a Potential New Strategy for Personalized Melanoma, Cancer Immunotherapy

Melanoma, News

Biotechnology company BioNTech AG recently announced the publication of a study entitled “Mutant MHC class II epitopes drive therapeutic immune responses to cancer” in the internationally renowned journal Nature. The ... Read more

April 29, 2015April 29, 2015

β-catenin Protein Activators Found to be Effective Against Melanoma Cells

Melanoma, News

A variety of therapeutic options for melanoma have been developed since 2011, changing the way advanced melanomas are treated. Some treatments focus on specific mutations found in melanoma patients, such as ... Read more

April 27, 2015April 27, 2015

Common Skin Mole Mutations Related To Hundreds Of Cancer Possibilities

Melanoma, News

An international team of scientists led by Houston Methodist researchers managed to identify in mice models hundreds of possible new genes that might transform benign skin growths into deadly melanomas. These results have been ... Read more

April 24, 2015April 24, 2015

Provectus and Pfizer Receive Patent Allowance for Experimental Therapy in Combination with Systemic Immunotherapy For Melanoma Treatment

Melanoma, News

Provectus Biopharmaceuticals, Inc. a company specialized in developing oncology and dermatology therapies, recently announced that is has received from the US Patent and Trademark Office a Notice of Allowance for ... Read more

April 23, 2015April 23, 2015

New Immunotherapy Reduces Tumors in Metastatic Melanoma Patients

Melanoma, News

Scientists at Penn Abramson Cancer Center recently presented groundbreaking results showing how combining an immune-checkpoint inhibitor – tremelimumab – with an anti-CD40 monoclonal antibody drug induces a safe and effective response ... Read more

April 22, 2015April 22, 2015

Promising Immunotherapy Combination for Patients with Untreated Melanoma Revealed in Study

News

A new study recently published in The New England Journal of Medicine revealed that a specific combination of immunotherapies yielded promising results in patients with untreated advanced melanoma. The study was ... Read more

April 21, 2015April 21, 2015

Stanford Researchers Discover a Cell Type Linked to Scar Formation, Fibrosis and Melanoma Growth

Melanoma, News

Researchers at Stanford University School of Medicine recently published in the journal Science the discovery of a specific skin cell type that is associated to wound healing by scarring, radiation-induced fibrosis ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group